Clinical Trials

Showing 1 - 2 of 2 clinical trials matching your search

NCT05653271

A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ACE1831, an Allogeneic CD20-conjugated gamma delta T-cell therapy, in Adult Subjects with Relapsed/Refractory CD20-expressing B-cell Malignancies

This study is currently enrolling.

Associated Conditions: Bone Cancer

Research Area: Clinical Cancer Research

A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of
ACE1831, an Allogeneic CD20-conjugated gamma delta T-cell therapy, in Adult Subjects with Relapsed/Refractory CD20-expressing B-cell...
Treatment of Bone Marrow Failure, Post Allogeneic Bone Marrow Transplant,w ith CD34+ Cell-Enriched Hematopoietic Stem Cell Infusion (Miltenyi Biotec's CliniMACS CD34 Reagent System) A HDE Treatment Protocol

This study is not currently enrolling.

Associated Conditions: Multiple Tumor Types

Research Area: Clinical Cancer Research

[Shell Only] - HUD/CUD.